20110613
 Corporate News: Epilepsy Pill From Glaxo, Valeant Gets FDA Backing   By Stovall, Sten, The Wall Street Journal,  Jun 14, 2011  GlaxoSmithKline PLC and Canadian partner Valeant Pharmaceuticals International Inc. said their epilepsy pill Potiga was approved by U.S. drug regulators as an add-on treatment for partial onset seizures.   
